![[NEWS] – Biofortis obtains ANSM authorization and strengthens its position in the development of microbiota-derived therapies](https://www.biofortis.fr/wp-content/uploads/2026/07/ANSM_Communication_June2026-1080x675.jpeg)
Our latest articles
- [NEWS] – Biofortis obtains ANSM authorization and strengthens its position in the development of microbiota-derived therapies July 8, 2026
- [EVENT] Biofortis, membre du comité d’organisation et Sponsor Silver de la Journée Nutrition & Microbiote 2025 September 23, 2025
- [EVENT] – Biofortis and analyze & realize will be present at Vitafoods Europe 2025 April 1, 2025
- [ARTICLE] The intestinal microbiota, a major player in colorectal cancer March 28, 2025
- [PRESS RELEASE] Biofortis and Teranga strengthen their service offerings with the acquisition of NEOVIX group March 7, 2025
- [ARTICLE] Kefir and Kombucha: are health promises justified? February 27, 2025